New Application Note for TAP’s ambr15 Micro Bioreactors
Product News Sep 12, 2014
TAP Biosystems has announced the availability of a new technical note on managing sample volume for its ambr15™ micro bioreactor system. This note will provide an invaluable guide for scientists to obtain critical data using easy-to-implement sampling regimes and analytical techniques, thus maximizing the capabilities of the ambr15 to make process development for biologics faster and less costly.
The new note reflects commonly employed ‘best practice’ for successful sampling strategies as implemented in major biopharmaceutical firms using ambr15 in their process development workflow.
The technical note provides advice on how low volume analyzers can be effectively used with the ambr15 and explains the sample types that can be automatically diluted using the ambr15’s liquid handling capabilities, enabling scientists to rapidly generate accurate process development results from small sample volumes.
The note also details how to intelligently maximize data generation by reducing sampling frequency and prioritizing assays, as well as explaining how to set up replicate cultures to increase volume available for sampling.
These include a worked example of a 14 day ambr15 bioprocess and an example experimental layout for an optimum sampling regime of replicates.
Using the details in this application note will allow bioprocess scientists to reduce their reliance on shake flasks and bench top bioreactors, reducing the amount of media and reagents required and saving many months of scale-up process development work.
The methods are available in a technical application note, which can be requested via the link:
Dr Barney Zoro, ambr15 Product Manager at TAP Biosystems stated: "Many traditional analyzers are not designed for use with micro scale bioreactors, so managing the culture volume when running ambr15 experiments requires planning. To make it as simple as possible for scientists to operate their ambr15 processes most effectively and get the key analytical data points that they need, we have distilled intelligent sampling strategies into this one handy application note, many of which have now been implemented by ambr15 users in major pharma companies.”
Zoro continued: “Utilizing the methods in this technical note will help scientists to accurately select the right cell lines and optimize their bioprocess parameters in weeks rather than months, using less media, reagents and staff time. This will ultimately enable ambr15 micro bioreactor users to rapidly develop robust, cost-effective manufacturing processes and affordable biologics.”